Terms: = Brain cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
4082 results:
1. Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches.
Alorfi NM; Ashour AM; Alharbi AS; Alshehri FS
Medicine (Baltimore); 2024 May; 103(21):e38245. PubMed ID: 38788009
[TBL] [Abstract] [Full Text] [Related]
2. The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort.
Li X; Wu D; Tang J; Wu Y
J Cancer Res Clin Oncol; 2024 May; 150(5):271. PubMed ID: 38780840
[TBL] [Abstract] [Full Text] [Related]
3. MR-based radiomics predictive modelling of EGFR mutation and HER2 overexpression in metastatic brain adenocarcinoma: a two-centre study.
Li Y; Jin Y; Wang Y; Liu W; Jia W; Wang J
Cancer Imaging; 2024 May; 24(1):65. PubMed ID: 38773634
[TBL] [Abstract] [Full Text] [Related]
4. Deformable registration of magnetic resonance images using unsupervised deep learning in neuro-/radiation oncology.
Osman AFI; Al-Mugren KS; Tamam NM; Shahine B
Radiat Oncol; 2024 May; 19(1):61. PubMed ID: 38773620
[TBL] [Abstract] [Full Text] [Related]
5. mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses.
Azimi P; Yazdanian T; Ahmadiani A
BMC Cancer; 2024 May; 24(1):612. PubMed ID: 38773447
[TBL] [Abstract] [Full Text] [Related]
6. Integrating Reinforcement Learning and Monte Carlo Tree Search for enhanced neoantigen vaccine design.
Lin Y; Ma J; Yuan H; Chen Z; Xu X; Jiang M; Zhu J; Meng W; Qiu W; Liu Y
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38770719
[TBL] [Abstract] [Full Text] [Related]
7. Survival Predictive Nomograms for Non-Surgical brain Metastases Patients From Non-Small Cell Lung cancer Receiving Radiotherapy: A Population-Based Study.
Li P; Luo J; Zheng Z; Meng L; Zhang A; Cao W; Gong X
Cancer Control; 2024; 31():10732748241255212. PubMed ID: 38769789
[TBL] [Abstract] [Full Text] [Related]
8. A longer time to relapse is associated with a larger increase in differences between paired primary and recurrent IDH wild-type glioblastomas at both the transcriptomic and genomic levels.
Ho WM; Chen CY; Chiang TW; Chuang TJ
Acta Neuropathol Commun; 2024 May; 12(1):77. PubMed ID: 38762464
[TBL] [Abstract] [Full Text] [Related]
9. Singular Value Decomposition-Based Penalized Multinomial Regression for Classifying Imbalanced Medulloblastoma Subgroups Using Methylation Data.
Mohammed I; Elbashir MK; Faggad AS
J Comput Biol; 2024 May; 31(5):458-471. PubMed ID: 38752890
[No Abstract] [Full Text] [Related]
10. SAROS: A dataset for whole-body region and organ segmentation in CT imaging.
Koitka S; Baldini G; Kroll L; van Landeghem N; Pollok OB; Haubold J; Pelka O; Kim M; Kleesiek J; Nensa F; Hosch R
Sci Data; 2024 May; 11(1):483. PubMed ID: 38729970
[TBL] [Abstract] [Full Text] [Related]
11. Quantification of attenuation and speckle features from endoscopic OCT images for the diagnosis of human brain glioma.
Aleksandrova PV; Zaytsev KI; Nikitin PV; Alekseeva AI; Zaitsev VY; Dolganov KB; Reshetov IV; Karalkin PA; Kurlov VN; Tuchin VV; Dolganova IN
Sci Rep; 2024 May; 14(1):10722. PubMed ID: 38729956
[TBL] [Abstract] [Full Text] [Related]
12. CDCA3 is a potential biomarker for glioma malignancy and targeted therapy.
Han C; Liu S; Ji Y; Hu Y; Zhang J
Medicine (Baltimore); 2024 May; 103(19):e38066. PubMed ID: 38728485
[TBL] [Abstract] [Full Text] [Related]
13. 'High hopes for treatment': Australian stakeholder perspectives of the clinical translation of advanced neurotherapeutics for rare neurological diseases.
Nguyen CQ; Kariyawasam DST; Ngai TSJ; Nguyen J; Alba-Concepcion K; Grattan SE; Palmer EE; Hetherington K; Wakefield CE; Dale RC; Woolfenden S; Mohammad S; Farrar MA
Health Expect; 2024 Jun; 27(3):e14063. PubMed ID: 38711219
[TBL] [Abstract] [Full Text] [Related]
14. Genetic variants for head size share genes and pathways with cancer.
Knol MJ; Poot RA; Evans TE; Satizabal CL; Mishra A; Sargurupremraj M; van der Auwera S; Duperron MG; Jian X; Hostettler IC; van Dam-Nolen DHK; Lamballais S; Pawlak MA; Lewis CE; Carrion-Castillo A; van Erp TGM; Reinbold CS; Shin J; Scholz M; Håberg AK; Kämpe A; Li GHY; Avinun R; Atkins JR; Hsu FC; Amod AR; Lam M; Tsuchida A; Teunissen MWA; Aygün N; Patel Y; Liang D; Beiser AS; Beyer F; Bis JC; Bos D; Bryan RN; Bülow R; Caspers S; Catheline G; Cecil CAM; Dalvie S; Dartigues JF; DeCarli C; Enlund-Cerullo M; Ford JM; Franke B; Freedman BI; Friedrich N; Green MJ; Haworth S; Helmer C; Hoffmann P; Homuth G; Ikram MK; Jack CR; Jahanshad N; Jockwitz C; Kamatani Y; Knodt AR; Li S; Lim K; Longstreth WT; Macciardi F; ; ; Mäkitie O; Mazoyer B; Medland SE; Miyamoto S; Moebus S; Mosley TH; Muetzel R; Mühleisen TW; Nagata M; Nakahara S; Palmer ND; Pausova Z; Preda A; Quidé Y; Reay WR; Roshchupkin GV; Schmidt R; Schreiner PJ; Setoh K; Shapland CY; Sidney S; St Pourcain B; Stein JL; Tabara Y; Teumer A; Uhlmann A; van der Lugt A; Vernooij MW; Werring DJ; Windham BG; Witte AV; Wittfeld K; Yang Q; Yoshida K; Brunner HG; Le Grand Q; Sim K; Stein DJ; Bowden DW; Cairns MJ; Hariri AR; Cheung CL; Andersson S; Villringer A; Paus T; Cichon S; Calhoun VD; Crivello F; Launer LJ; White T; Koudstaal PJ; Houlden H; Fornage M; Matsuda F; Grabe HJ; Ikram MA; Debette S; Thompson PM; Seshadri S; Adams HHH
Cell Rep Med; 2024 May; 5(5):101529. PubMed ID: 38703765
[TBL] [Abstract] [Full Text] [Related]
15. Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes.
Yang Y; More S; De Smet F; De Vleeschouwer S; Agostinis P
Front Immunol; 2024; 15():1342977. PubMed ID: 38698847
[TBL] [Abstract] [Full Text] [Related]
16. Ensemble learning prediction framework for EGFR amplification status of glioma based on terahertz spectral features.
Wu X; Tao R; Sun Z; Zhang T; Li X; Yuan Y; Zheng S; Cao C; Zhang Z; Zhao X; Yang P
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Aug; 316():124351. PubMed ID: 38692109
[TBL] [Abstract] [Full Text] [Related]
17. Classification of Glioblastoma Associated with Immune Checkpoints and Tumor Microenvironment based on Immunogenomic Profiling.
Zheng P; Zhang X; Ren D; Bai Q
Neurol India; 2024 Mar; 72(2):297-303. PubMed ID: 38691473
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of Human Colorectal cancer by a Natural Product 7-Acetylhorminone and Interactions with BSA/HSA: Multispectral Analysis and In Silico and In Vitro Studies.
Pakrashy S; Chakraborty S; Manna S; Nanda Goswami J; Bhattacharya B; Emmerling F; Mandal J; Misra S; Maiti Choudhury S; Okla MK; Bose A; Maurya PK; Majhi A; Dolai M
ACS Appl Bio Mater; 2024 May; 7(5):3414-3430. PubMed ID: 38687465
[TBL] [Abstract] [Full Text] [Related]
19. Multi-Omics Pan-cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities.
Chen Y; Xiao C; Fan Q; Zhang Y; Huang Q; Ou Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):151. PubMed ID: 38682182
[TBL] [Abstract] [Full Text] [Related]
20. Saliva-based microRNA diagnostic signature for the superficial peritoneal endometriosis phenotype.
Bendifallah S; Dabi Y; Suisse S; Ilic J; Delbos L; Poilblanc M; Descamps P; Golfier F; Jornea L; Bouteiller D; Touboul C; Puchar A; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():187-196. PubMed ID: 38677096
[TBL] [Abstract] [Full Text] [Related]
[Next]
